Business Standard

Monday, December 23, 2024 | 01:31 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Top headlines: Astra booster works against Omicron; Paym sees senior exits?

Business Standard brings you the top headlines on Thursday

Illustration: Reuters
Premium

Illustration: Reuters

BS Web Team New Delhi
Serum Institute on the up as Oxford study backs Astra booster for Omicron

A third booster shot of the AstraZeneca-Oxford Covid-19 vaccine, Vaxzevria, significantly boosts antibodies against the Omicron variant of the coronavirus, said the British drug company.

This brightens the scope for Serum Institute of India (SII) which makes Covishield, the domestic version of the Vaxzevria. Experts believe mixing vaccine shots may give better results in boosting immunity. Read more

IOC to invest Rs 9,028 crore for setting up a new crude oil pipeline

Indian Oil Corporation (IOC) will set up a new crude oil pipeline

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in